TCF12 is mutated in anaplastic oligodendroglioma

Nature Communications

Volumn 6, Issue , 2015, Pages

  Labreche, Karim ^a,b,c,d   Simeonova, Iva ^b,c,d   Kamoun, Aurélie ^e   Gleize, Vincent ^b,c,d   Chubb, Daniel ^a   Letouzé, Eric ^e   Riazalhosseini, Yasser ^f   Dobbins, Sara E ^a   Elarouci, Nabila ^e   Ducray, Francois ^g   De Reyniès, Aurélien ^e   Zelenika, Diana ^h   Wardell, Christopher P ^a   Frampton, Mathew ^a   Saulnier, Olivier ^b,c,d   Pastinen, Tomi ^f   Hallout, Sabrina ^b,c,d   Figarella Branger, Dominique ^i,j   Dehais, Caroline ^k   Idbaih, Ahmed ^b,c,d,k   Mokhtari, Karima ^b,c,d,k   Delattre, Jean Yves ^b,c,d,k   Huillard, Emmanuelle ^b,c,d   Mark Lathrop, G ^f   Sanson, Marc ^b,c,d,k   Houlston, Richard S ^a   Adam, Clovis ^l   Andraud, Marie ^m   Aubriot Lorton, Marie Hélène ⁿ   Bauchet, Luc ^o   Beauchesne, Patrick ^p   Blechet, Claire ^q   Campone, Mario ^r   Carpentier, Antoine ^s   Carpentier, Catherine ^t   Carpiuc, Ioana ^u   Chenard, Marie Pierre ^v   Chiforeanu, Danchristian ^w   Chinot, Olivier ⁱ   Cohen Moyal, Elisabeth ^x   Colin, Philippe ^y   Dam Hieu, Phong ^z   Desenclos, Christine ^aa   Desse, Nicolas ^ab   Dhermain, Frederic ^ac   Diebold, Marie Danièle ^ad   Eimer, Sandrine ^ae   Faillot, Thierry ^af   Fesneau, Mélanie ^q   Fontaine, Denys ^ag   Gaillard, Stéphane ^ah   Gauchotte, Guillaume ^p   Gaultier, Claude ^ai   Ghiringhelli, Francois ^aj   Godard, Joel ^ak   Gueye, Edouard Marcel ^al   Guillamo, Jean Sebastien ^am   Hamdi Elouadhani, Selma ^an   Honnorat, Jerome ^g   Kemeny, Jean Louis ^ao   Khallil, Toufik ^ao   Jouvet, Anne ^g   Labrousse, Francois ^al   Langlois, Olivier ^ap   Laquerriere, Annie ^ap   Lechapt Zalcman, Emmanuelle ^am   Le Guérinel, Caroline ^aq   Levillain, Pierre Marie ^ar   Loiseau, Hugues ^ae   Loussouarn, Delphine ^as   Maurage, Claude Alain ^at   Menei, Philippe ^au   Motsuo Fotso, Marie Janette ^av   Noel, Georges ^aw   Parker, Fabrice ^l   Peoc'H, Michel ^av   Polivka, Marc ^an   Quintin Roué, Isabelle ^z   Ramirez, Carole ^at   Ricard, Damien ^ax   Richard, Pomone ^ay   Rigau, Valérie ^o   Rousseau, Audrey ^au   Runavot, Gwenaelle ^m   Sevestre, Henri ^aa   Tortel, Marie Christine ^ai   Uro Coste, Emmanuelle ^az   Burel Vandenbos, Fanny ^ag   Vauleon, Elodie ^ba   Viennet, Gabriel ^ak   Villa, Chiara ^ah   Wager, Michel ^ar   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSERM   (France)

^c CNRS   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e Ligue Nationale Contre le Cancer   (France)

^f MCGILL UNIVERSITY   (Canada)

^g HÔPITAL NEUROLOGIQUE   (France)

^h DIF   (France)

ⁱ TIMONE HOSPITAL   (France)

^j AIX MARSEILLE UNIVERSITY   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l BICÊTRE HOSPITAL   (France)

^m Groupe Hospitalier Sud Réunion   (France)

ⁿ DIJON UNIVERSITY HOSPITAL   (France)

^o MONTPELLIER UNIVERSITY HOSPITAL   (France)

^p UNIVERSITY HOSPITAL OF NANCY   (France)

^q CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^r CENTRE RENÉ GAUDUCHEAU   (France)

^s AVICENNE HOSPITAL   (France)

^t SORBONNE UNIVERSITÉ   (France)

^u Service d'Imagerie   (France)

^v UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^w RENNES UNIVERSITY HOSPITAL   (France)

^x INSTITUT CLAUDIUS REGAUD   (France)

^y Clinique de Courlancy   (France)

^z SERVICE DE RHUMATOLOGIE   (France)

^aa AMIENS UNIVERSITY HOSPITAL   (France)

^ab Military Teaching Hospital Sainte Anne   (France)

^ac INSTITUT GUSTAVE ROUSSY   (France)

^ad REIMS UNIVERSITY HOSPITAL   (France)

^ae BORDEAUX UNIVERSITY HOSPITAL   (France)

^af BEAUJON HOSPITAL   (France)

^ag UNIVERSITY HOSPITAL OF NICE   (France)

^ah FOCH HOSPITAL   (France)

^ai Service de Neurologie/CH de Colmar   (France)

^aj CENTRE GEORGES FRANÇOIS LECLERC   (France)

^ak UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^al DUPUYTREN UNIVERSITY HOSPITAL   (France)

^am CAEN UNIVERSITY HOSPITAL   (France)

^an HÔPITAL LARIBOISIÈRE   (France)

^ao UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^ap HÔPITAL CHARLES NICOLLE   (France)

^aq HENRI MONDOR HOSPITAL   (France)

^ar POITIERS UNIVERSITY HOSPITAL   (France)

^as NANTES UNIVERSITY HOSPITAL   (France)

^at LILLE UNIVERSITY HOSPITAL   (France)

^au ANGERS UNIVERSITY HOSPITAL   (France)

^av HÔPITAL NORD   (France)

^aw CENTRE PAUL STRAUSS   (France)

^ax University of Paris Descartes   (France)

^ay Laboratoire de pathologie des Feuillants   (France)

^az CHU RANGUEIL   (France)

^ba CENTRE EUGÈNE MARQUIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR TCF12; TRANSCRIPTOME; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; TCF12 PROTEIN, HUMAN;

BIOMARKER; BRAIN; CANCER; CHROMOSOME; GENE EXPRESSION; MUTATION; NUCLEIC ACID ANALYSIS; POLYMORPHISM; PROTEIN; TUMOR; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHROMOSOME 4; CHROMOSOME ARM; CITRIC ACID CYCLE; COLON CANCER; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; E BOX ELEMENT; EMBRYO; EXOME; EXON; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE ONTOLOGY; GENE SEQUENCE; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MITOSIS INDEX; MUTATION; MUTATION RATE; OLIGODENDROGLIA; OLIGODENDROGLIOMA; RNA SEQUENCE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; STOP CODON; TRANSACTIVATION; BRAIN TUMOR; DOWN REGULATION; GENETICS; TRANSCRIPTION INITIATION; VALIDATION STUDY;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; DOWN-REGULATION; HUMANS; MUTATION; OLIGODENDROGLIOMA; TRANSCRIPTIONAL ACTIVATION;

EID: 84935896707     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8207     Document Type: Article

References (40)

1. Cairncross, G. et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J. Clin. Oncol. 31, 337-343 (2013).
2. Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl Acad. Sci. USA 110, 6021-6026 (2013).
3. Riemenschneider, M. J., Koy, T. H. & Reifenberger, G. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas. Acta Neuropathol. 107, 277-282 (2004).
4. Bettegowda, C. et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333, 1453-1455 (2011).
5. Yip, S. et al. Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J. Pathol. 226, 7-16 (2012).
6. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N Engl. J. Med. 360, 765-773 (2009).
7. Labussiere, M. et al. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology 74, 1886-1890 (2010).
8. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
9. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
10. Sharma, V. P. et al. Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat. Genet. 45, 304-307 (2013).
11. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462-477 (2013).
12. Singh, D. et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337, 1231-1235 (2012).
13. Di Stefano, A. L. et al. Detection, characterization and inhibition of FGFR-TACC fusions in IDH wild type glioma. Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-2199 (2015).
14. Gonzalez-Perez, A. & Lopez-Bigas, N. Functional impact bias reveals cancer drivers. Nucleic Acids Res. 40, e169 (2012).
15. Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081-1082 (2013).
16. Seshagiri, S. et al. Recurrent R-spondin fusions in colon cancer. Nature 488, 660-664 (2012).
17. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120 (2012).
18. Lee, C. C. et al. TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J. Biol. Chem. 287, 2798-2809 (2012).
19. Sideridou, M. et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J. Cell Biol. 195, 1123-1140 (2011).
20. Yang, M. H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 12, 982-992 (2010).
21. Uittenbogaard, M. & Chiaramello, A. Expression of the bHLH transcription factor Tcf12 (ME1) gene is linked to the expansion of precursor cell populations during neurogenesis. Brain Res. Gene Expr. Patterns 1, 115-121 (2002).
22. Fu, H. et al. A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J. Neurosci. 29, 11399-11408 (2009).
23. Paredes, J. et al. Epithelial E-and P-cadherins: role and clinical significance in cancer. Biochim. Biophys. Acta 1826, 297-311 (2012).
24. Paumard-Hernandez, B. et al. Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants. Eur. J. Hum. Genet. doi: 10.1038/ejhg.2014.205 (2014).
25. Kleihues, P. & Cavenee, W. E. World Health Organisation Classification of Tumours of the Central Nervous System (WHO/IARC, 2000).
26. Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
27. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
28. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
29. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
30. Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41, e67 (2013).
31. Iyer, M. K., Chinnaiyan, A. M. & Maher, C. A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27, 2903-2904 (2011).
32. Maher, C. A. et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc. Natl Acad. Sci. USA 106, 12353-12358 (2009).
33. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
34. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
35. Hubble, J. et al. Implementation of GenePattern within the Stanford Microarray Database. Nucleic Acids Res. 37, D898-D901 (2009).
36. Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201 (2006).
37. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33-38 27-8 (1996).
38. Russell, R. B. & Barton, G. J. Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins 14, 309-323 (1992).
39. Venselaar, H., Te Beek, T. A., Kuipers, R. K., Hekkelman, M. L. & Vriend, G. Protein structure analysis of mutations causing inheritable diseases. an e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 11, 548 (2010).
40. Farrington, C. P. & Manning, G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat. Med. 9, 1447-1454 (1990).